These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24194849)

  • 1. Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury.
    Hadass O; Tomlinson BN; Gooyit M; Chen S; Purdy JJ; Walker JM; Zhang C; Giritharan AB; Purnell W; Robinson CR; Shin D; Schroeder VA; Suckow MA; Simonyi A; Sun GY; Mobashery S; Cui J; Chang M; Gu Z
    PLoS One; 2013; 8(10):e76904. PubMed ID: 24194849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse.
    Semple BD; Noble-Haeusslein LJ; Gooyit M; Tercovich KG; Peng Z; Nguyen TT; Schroeder VA; Suckow MA; Chang M; Raber J; Trivedi A
    PLoS One; 2015; 10(11):e0143386. PubMed ID: 26588471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-9 inhibitor SB-3CT attenuates behavioral impairments and hippocampal loss after traumatic brain injury in rat.
    Jia F; Yin YH; Gao GY; Wang Y; Cen L; Jiang JY
    J Neurotrauma; 2014 Jul; 31(13):1225-34. PubMed ID: 24661104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Water-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.
    Lee M; Chen Z; Tomlinson BN; Gooyit M; Hesek D; Juárez MR; Nizam R; Boggess B; Lastochkin E; Schroeder VA; Wolter WR; Suckow MA; Cui J; Mobashery S; Gu Z; Chang M
    ACS Chem Neurosci; 2015 Oct; 6(10):1658-64. PubMed ID: 26241578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.
    Cui J; Chen S; Zhang C; Meng F; Wu W; Hu R; Hadass O; Lehmidi T; Blair GJ; Lee M; Chang M; Mobashery S; Sun GY; Gu Z
    Mol Neurodegener; 2012 May; 7():21. PubMed ID: 22587708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective gelatinase inhibitor neuroprotective agents cross the blood-brain barrier.
    Gooyit M; Suckow MA; Schroeder VA; Wolter WR; Mobashery S; Chang M
    ACS Chem Neurosci; 2012 Oct; 3(10):730-6. PubMed ID: 23077716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 regulates the blood brain barrier via the hedgehog pathway in a rat model of traumatic brain injury.
    Wu MY; Gao F; Yang XM; Qin X; Chen GZ; Li D; Dang BQ; Chen G
    Brain Res; 2020 Jan; 1727():146553. PubMed ID: 31734396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MMP-9 activity following hypoxic ischemia in the developing brain using a highly specific inhibitor.
    Ranasinghe HS; Scheepens A; Sirimanne E; Mitchell MD; Williams CE; Fraser M
    Dev Neurosci; 2012; 34(5):417-27. PubMed ID: 23171520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.
    Ye Y; Kuang X; Xie Z; Liang L; Zhang Z; Zhang Y; Ma F; Gao Q; Chang R; Lee HH; Zhao S; Su J; Li H; Peng J; Chen H; Yin M; Peng C; Yang N; Wang J; Liu J; Liu H; Han L; Chen X
    Genome Med; 2020 Sep; 12(1):83. PubMed ID: 32988398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 9 inhibition reduces early brain injury in cortex after subarachnoid hemorrhage.
    Guo ZD; Zhang XD; Wu HT; Lin B; Sun XC; Zhang JH
    Acta Neurochir Suppl; 2011; 110(Pt 1):81-4. PubMed ID: 21116920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice.
    Chen S; Chen Z; Cui J; McCrary ML; Song H; Mobashery S; Chang M; Gu Z
    eNeuro; 2018; 5(3):. PubMed ID: 29963617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
    Majeed S; Singh P; Sharma N; Sharma S
    BMC Infect Dis; 2016 Nov; 16(1):722. PubMed ID: 27899068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Matrix Metalloproteinase 9 Enhances Rod Survival in the S334ter-line3 Retinitis Pigmentosa Model.
    Shin JA; Kim HS; Vargas A; Yu WQ; Eom YS; Craft CM; Lee EJ
    PLoS One; 2016; 11(11):e0167102. PubMed ID: 27893855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-9 inhibitors impair learning in spontaneously hypertensive rats.
    Raz L; Yang Y; Thompson J; Hobson S; Pesko J; Mobashery S; Chang M; Rosenberg G
    PLoS One; 2018; 13(12):e0208357. PubMed ID: 30533010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Exploration of the effect of inhibitor of matrix metalloproteinase-9 on blood brain barrier in cardiopulmonary resuscitation in rats].
    He ZJ; Zou ZJ; Chen XT
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Jun; 21(6):337-9. PubMed ID: 19570337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
    Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
    J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors.
    Gooyit M; Lee M; Hesek D; Boggess B; Oliver AG; Fridman R; Mobashery S; Chang M
    Chem Biol Drug Des; 2009 Dec; 74(6):535-46. PubMed ID: 19824893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) produces edema due to BBB disruption induced by MMP-9 activation in rat hippocampus.
    Pérez-Hernández M; Fernández-Valle ME; Rubio-Araiz A; Vidal R; Gutiérrez-López MD; O'Shea E; Colado MI
    Neuropharmacology; 2017 May; 118():157-166. PubMed ID: 28322979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.
    Tao P; Fisher JF; Shi Q; Mobashery S; Schlegel HB
    J Phys Chem B; 2010 Jan; 114(2):1030-7. PubMed ID: 20039633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 potentiates early brain injury after subarachnoid hemorrhage.
    Guo Z; Sun X; He Z; Jiang Y; Zhang X; Zhang JH
    Neurol Res; 2010 Sep; 32(7):715-20. PubMed ID: 19703360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.